TXNL1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to TXNL1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World	PHASE4	UNKNOWN
Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease	PHASE3	COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer	PHASE1	COMPLETED
Tolerability of Enteral NAC in Infants	PHASE1	NOT_YET_RECRUITING
S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304	nan	COMPLETED
Thiol/Disulphide Homeostasis in Unexplained Infertility	nan	COMPLETED
Correlation Research of Thioredoxin Reductase in Lung Cancer	nan	COMPLETED
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea	nan	RECRUITING
External Nitric Oxide Measurement Through SNO Degradation	nan	ENROLLING_BY_INVITATION
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics	nan	COMPLETED
Thermogenic Silencer Regulatory Factors in Humans	nan	ACTIVE_NOT_RECRUITING
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism	nan	UNKNOWN
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)	nan	RECRUITING
Telomere Disclosure and Impact on Psychological Distress and Health Behaviors	nan	COMPLETED
Biomarker Panel in Ovarian Torsion	nan	UNKNOWN
A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia	nan	COMPLETED
Autophagy Bladder Cancer	nan	UNKNOWN
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis	nan	UNKNOWN
Genetic Characterization of Parkinson's Disease	nan	COMPLETED
The Canadian Multicentre CSF Monitoring and Biomarker Study	nan	COMPLETED
Evaluation of Mitochondrial Enzyme Activity in Cesarean Section Patients	nan	UNKNOWN
Tecfidera Diffusion Tensor Imaging	nan	COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases	nan	UNKNOWN
Primary Hyperoxaluria Mutation Genotyping/Phenotyping	nan	COMPLETED
Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis	nan	COMPLETED
Cell Signaling and Resistance to Oxidative Stress: Effects of Aging and Exercise	nan	COMPLETED
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise	nan	COMPLETED
Hemochromatosis and Iron Overload Screening Study (HEIRS)	nan	COMPLETED
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy	nan	COMPLETED
Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a TXNL1 binder may also engage these)

Protein	Name	Similarity
Q8CDN6	—	1.000	Q8CDN6 →
Q920J4	—	1.000	Q920J4 →
Q9SQZ9	—	0.977	Q9SQZ9 →
Q9USR1	—	0.976	Q9USR1 →
P31669	—	0.973	P31669 →
Q6DJI5	—	0.972	Q6DJI5 →
Q8BWR2	—	0.971	Q8BWR2 →
P53620	—	0.971	P53620 →
Q9I8E6	—	0.971	Q9I8E6 →
Q6NYX8	—	0.970	Q6NYX8 →
Q0VD48	—	0.970	Q0VD48 →
Q9QZE5	—	0.969	Q9QZE5 →
Q5E9A6	—	0.969	Q5E9A6 →
P22892	—	0.969	P22892 →
Q9PUE4	—	0.969	Q9PUE4 →
P27008	—	0.969	P27008 →
Q29L80	—	0.969	Q29L80 →
Q920B9	—	0.969	Q920B9 →
Q5E9R3	—	0.968	Q5E9R3 →
COPG1	Coatomer subunit gamma-1	0.968	landscape →
Q9VGV8	—	0.968	Q9VGV8 →
Q9WVK4	—	0.968	Q9WVK4 →
O02485	—	0.968	O02485 →
AP1G1	AP-1 complex subunit gamma-1	0.968	landscape →
Q9NZN3	—	0.968	Q9NZN3 →
SUPT16H	FACT complex subunit SPT16	0.968	landscape →
Q9QXK3	—	0.968	Q9QXK3 →
Q23670	—	0.967	Q23670 →
Q64511	—	0.967	Q64511 →
P42942	—	0.967	P42942 →